Crossmark

Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials

Crossref DOI link: https://doi.org/10.1038/s41372-020-0603-7

Published Online: 2020-02-12

Published Print: 2020-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sánchez Luna, Manuel https://orcid.org/0000-0001-9543-7392
Bacher, Peter

Unnebrink, Kristina

Martinez-Tristani, Marisol

Ramos Navarro, Cristina
Funding

Funding for this research was provided by:

AbbVie
License Information

Text and Data Mining valid from 2020-02-12

Version of Record valid from 2020-02-12
More Information

Article History

Received: 23 August 2019

Revised: 16 December 2019

Accepted: 31 January 2020

First Online: 12 February 2020

Compliance with ethical standards

:

: MSL received travel and lectures grants from AbbVie Inc. and served as a consultant for Chiesi and AbbVie. CRN has no relevant conflicts of interest. PB, KU, and MM-T are employees of AbbVie and may own AbbVie stock and/or stock options.

Document is current

Any future updates will be listed below